HealingMaps.com
HealingMaps.com is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at HealingMaps.com.
HealingMaps.com is a company.
Key people at HealingMaps.com.
Key people at HealingMaps.com.
HealingMaps.com, operating as HealingMaps Inc., is a directory and educational platform that connects individuals seeking psychedelic-assisted therapies, such as ketamine clinics, psilocybin retreats, and TMS (transcranial magnetic stimulation) providers, primarily in the US and globally.[1][2][5] It serves patients with mental health challenges by offering accurate information on treatments like IV/IM ketamine infusions, Spravato, and ketamine-assisted psychotherapy (KAP), solving the problem of fragmented access to trusted providers amid around 2,500 US ketamine clinics (only ~20% offering KAP).[2][5] The company has shown growth through a $1M seed round in 2022, a beta chatbot launch boosting engagement by 15% in 2024, and the 2025 launch of the Healing Health Alliance—a Group Purchasing Organization (GPO) joint venture to cut costs for clinics.[1]
HealingMaps emerged from the need for honest, centralized information on psychedelic therapies, inspired by expanding research and legal access to treatments like ketamine for mental health.[2] Founded prior to its 2022 seed funding (exact year not specified in available data), the company raised $1M led by Phyto Partners and Ambria Capital, with Cody Shandraw joining as Board Chairman.[1] Cory Jones serves as CEO, driving initiatives like the vellum.ai-powered chatbot and the Healing Health Alliance with Capstone Management Group.[1] Early traction included building a comprehensive directory, evolving from education to operational support for the ecosystem.[1][2]
HealingMaps rides the psychedelic renaissance trend, fueled by FDA-approved ketamine (Spravato) and emerging psilocybin access, amid mental health crises where traditional treatments fall short.[2] Timing aligns with regulatory evolution—clinicians view non-KAP infusions as gateways to deeper therapies—positioning it amid ~2,500 US clinics facing cost pressures.[1][2] Market forces like rising operational expenses favor its GPO model, while its directory influences ecosystem growth by standardizing discovery and education, bridging patients to providers and fostering industry newsletters/professional services.[1][5]
HealingMaps is poised to dominate as the go-to hub for psychedelic therapy amid legalization momentum and clinic proliferation, with expansions like the GPO signaling a shift from directory to full-service enabler.[1] Trends in insurance coverage, KAP adoption (expected to rise), and AI personalization will shape its path, potentially scaling via partnerships and data-driven insights.[1][2] Its influence may evolve into a ketamine/psychedelics powerhouse, empowering independents against big pharma while educating the "psychedelic-curious"—cementing its role in transforming mental health access.[1][2]
